Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells

被引:93
|
作者
Libiad, Marouane [1 ]
Vitvitsky, Victor [1 ]
Bostelaar, Trever [1 ]
Bak, Daniel W. [4 ]
Lee, Ho-Joon [2 ]
Sakamoto, Naoya [5 ]
Fearon, Eric [3 ]
Lyssiotis, Costas A. [2 ,3 ]
Weerapana, Eranthie [4 ]
Banerjee, Ruma [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[4] Boston Coll, Chem Dept, Chestnut Hill, MA 02467 USA
[5] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima 7348553, Japan
基金
美国国家卫生研究院;
关键词
cell metabolism; hydrogen sulfide; bioenergetics; colorectal cancer; cell signaling; redox signaling; colonocytes; gut epithelium; metabolic reprogramming; microbiome; OXIDATION; PROTEIN; THIOSULFATE; GROWTH;
D O I
10.1074/jbc.RA119.009442
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Unlike most other tissues, the colon epithelium is exposed to high levels of H2S derived from gut microbial metabolism. H2S is a signaling molecule that modulates various physiological effects. It is also a respiratory toxin that inhibits complex IV in the electron transfer chain (ETC). Colon epithelial cells are adapted to high environmental H2S exposure as they harbor an efficient mitochondrial H2S oxidation pathway, which is dedicated to its disposal. Herein, we report that the sulfide oxidation pathway enzymes are apically localized in human colonic crypts at the host-microbiome interface, but that the normal apical-to-crypt gradient is lost in colorectal cancer epithelium. We found that sulfide quinone oxidoreductase (SQR), which catalyzes the committing step in the mitochondrial sulfide oxidation pathway and couples to complex III, is a critical respiratory shield against H2S poisoning. H2S at concentrations <= 20 mu m stimulated the oxygen consumption rate in colon epithelial cells, but, when SQR expression was ablated, H2S concentrations as low as 5 mu m poisoned cells. Mitochondrial H2S oxidation altered cellular bioenergetics, inducing a reductive shift in the NAD(+)/NADH redox couple. The consequent electron acceptor insufficiency caused uridine and aspartate deficiency and enhanced glutamine-dependent reductive carboxylation. The metabolomic signature of this H2S-induced stress response mapped, in part, to redox-sensitive nodes in central carbon metabolism. Colorectal cancer tissues and cell lines appeared to counter the growth-restricting effects of H2S by overexpressing sulfide oxidation pathway enzymes. Our findings reveal an alternative mechanism for H2S signaling, arising from alterations in mitochondrial bioenergetics that drive metabolic reprogramming
引用
收藏
页码:12077 / 12090
页数:14
相关论文
共 50 条
  • [41] LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells
    Gibellini, Lara
    Losi, Lorena
    De Biasi, Sara
    Nasi, Milena
    Lo Tartaro, Domenico
    Pecorini, Simone
    Patergnani, Simone
    Pinton, Paolo
    De Gaetano, Anna
    Carnevale, Gianluca
    Pisciotta, Alessandra
    Mariani, Francesco
    Roncucci, Luca
    Iannone, Anna
    Cossarizza, Andrea
    Pinti, Marcello
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [42] Hydrogen Sulfide Modulates the S-Nitrosoproteome and the Mitochondrial Morphology in Endothelial Cells
    Chiu, Tsan-Wan
    Chen, Ying-Lun
    Wu, Chien-Yi
    Yu, Pei-Ling
    Shieh, Ying-Hua
    Huang, Bin
    ACTA CARDIOLOGICA SINICA, 2016, 32 (05) : 604 - 611
  • [43] Rhodamine-propargylic esters for detection of mitochondrial hydrogen sulfide in living cells
    Chen, Xi
    Wu, Shuqi
    Han, Jiahuai
    Han, Shoufa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) : 5295 - 5299
  • [44] METABOLIC REPROGRAMMING AND MITOCHONDRIAL DYSFUNCTION IN HepG2 CELLS AS POTENTIAL DRIVERS OF AIP PATHOPHYSIOLOGY
    Longo, Miriam
    Meroni, Marica
    Paolini, Erika
    Cappellini, Maria Domenica
    Motta, Irene
    Fracanzani, Anna Ludovica
    Di Pierro, Elena
    Dongiovanni, Paola
    HEPATOLOGY, 2020, 72 : 236A - 237A
  • [45] A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
    Yoo, Hee Chan
    Park, Seung Joon
    Nam, Miso
    Kang, Juwon
    Kim, Kibum
    Yeo, Joo Hye
    Kim, Joon-Ki
    Heo, Yunkyung
    Lee, Hee Seung
    Lee, Myeong Youl
    Lee, Chang Woo
    Kang, Jong Soon
    Kim, Yun-Hee
    Lee, Jinu
    Choi, Junjeong
    Hwang, Geum-Sook
    Bang, Seungmin
    Han, Jung Min
    CELL METABOLISM, 2020, 31 (02) : 267 - +
  • [46] Metabolic reprogramming and mitochondrial dysfunction in HepG2 cells as potential drivers of AIP pathophysiology
    Longo, M.
    Meroni, M.
    Paolini, E.
    Cappellini, M. D.
    Motta, I.
    Fracanzani, A. L.
    Di Pierro, E.
    Dongiovanni, P.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S19 - S19
  • [47] Metabolic Reprogramming of Human Cells in Response to Oxidative Stress: Implications in the Pathophysiology and Therapy of Mitochondrial Diseases
    Wu, Yu-Ting
    Wu, Shi-Bei
    Wei, Yau-Huei
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (35) : 5510 - 5526
  • [48] Correction: Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity
    Rida Iftikhar
    Harrison M. Penrose
    Angelle N. King
    Joshua S. Samudre
    Morgan E. Collins
    Alifiani B. Hartono
    Sean B. Lee
    Frank Lau
    Melody Baddoo
    Erik F. Flemington
    Susan E. Crawford
    Suzana D. Savkovic
    Oncogenesis, 11
  • [49] SIRT3 and Metabolic Reprogramming Mediate the Antiproliferative Effects of Whey in Human Colon Cancer Cells
    D'Onofrio, Nunzia
    Martino, Elisa
    Balestrieri, Anna
    Mele, Luigi
    Neglia, Gianluca
    Balestrieri, Maria Luisa
    Campanile, Giuseppe
    CANCERS, 2021, 13 (20)
  • [50] METABOLIC REPROGRAMMING TO HIGHER OXIDATIVE PHOSPHORYLATION ACTIVITY TRIGGERS APOPTOSIS IN MCF-7 HUMAN BREAST CARCINOMA CELLS
    Ibrahim, Sherif
    Sinko, Patrick J.
    DRUG METABOLISM REVIEWS, 2007, 39 : 358 - 359